Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003795
Status:
COMPLETED
Last Update Posted:
2013-05-27
First Post:
1999-11-01
Brief Title:
Quality of Life in Survivors of Gynecologic Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
GOG Foundation
Study Overview
Official Title:
Quality of Life of Gynecologic Cancer Survivors
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Quality-of-life assessment in cancer survivors may help determine the long-term effects of having had gynecologic cancer and may help improve the quality of life for future cancer survivors
PURPOSE This clinical trial is studying the quality of life in survivors of gynecologic cancer
PURPOSE This clinical trial is studying the quality of life in survivors of gynecologic cancer
Detailed Description:
OBJECTIVES
Describe the significant quality of life QOL concerns and long term survivorship issues of women diagnosed and treated for early stage ovarian and endometrial cancer five or more years ago
Identify mechanisms which contribute to a gynecologic cancer survivorship model through comparison and prediction of high versus low QOL associated with long term adjustment and survivorship Examine social support coping efforts self-efficacy meaning associated with survivorship performance status and age at diagnosis as potential predictors
Identify and compare factors that predict high versus low QOL for women with early stage endometrial cancer completing participation in GOG-99 clinical trial Conduct exploratory analysis examining long term QOL concerns of survivors randomized to surgery arm with or without radiotherapy
OUTLINE Patients complete one telephone interview with a professional female interviewer The interview lasts approximately 60 minutes and is audiotaped
PROJECTED ACCRUAL A total of 197 early stage endometrial cancer survivors and 114 early stage ovarian cancer survivors will be accrued for this study within 2 years
Describe the significant quality of life QOL concerns and long term survivorship issues of women diagnosed and treated for early stage ovarian and endometrial cancer five or more years ago
Identify mechanisms which contribute to a gynecologic cancer survivorship model through comparison and prediction of high versus low QOL associated with long term adjustment and survivorship Examine social support coping efforts self-efficacy meaning associated with survivorship performance status and age at diagnosis as potential predictors
Identify and compare factors that predict high versus low QOL for women with early stage endometrial cancer completing participation in GOG-99 clinical trial Conduct exploratory analysis examining long term QOL concerns of survivors randomized to surgery arm with or without radiotherapy
OUTLINE Patients complete one telephone interview with a professional female interviewer The interview lasts approximately 60 minutes and is audiotaped
PROJECTED ACCRUAL A total of 197 early stage endometrial cancer survivors and 114 early stage ovarian cancer survivors will be accrued for this study within 2 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GOG-9902 | None | None | None |